SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.05-0.9%9:52 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (3505)4/21/2001 11:38:21 AM
From: scaram(o)uche  Read Replies (3) of 52153
 
quote.yahoo.com

quote.yahoo.com

quote.yahoo.com

One couldn't have performed that poorly without trying, IMO. Performance at that level is laughable. And Murphy picks before starting the fund in '98 are known for being about as bad as they come.

There is not *one* specific short recommendation in that article. Not one. Cowardly. Once again, it's "hit on the sector" time, without courage to project even one valuation model.

Know what I don't like about thestreet.bomb? Putting words on paper is more important than insight, IMO. Furthermore, there is this ongoing attempt to drive opinion when they could provide company-specific analysis for potential 10-baggers.

Once again, in the face of all this bullshit....... the route to superior returns in biotech.....

1. find small-caps with leveraged business plans and hot science, and

2. put together a diversified basket of such creatures.

A new wrinkle, given the spotlight on the sector in the past two years and the new-age volatility...... wait for the dumbies at thestreet.bomb, their cronies, and other idiots to make mistakes, and then double down.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext